{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:32:16Z","timestamp":1697434336058},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:00:00Z","timestamp":1434412800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12872-015-0052-y","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T10:19:22Z","timestamp":1434363562000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical indicators for recurrent cardiovascular events in acute coronary syndrome patients treated with statins under routine practice in Thailand: an observational study"],"prefix":"10.1186","volume":"15","author":[{"given":"Dujrudee","family":"Chinwong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayanton","family":"Patumanond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surarong","family":"Chinwong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khanchai","family":"Siriwattana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siriluck","family":"Gunaparn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Joseph","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arintaya","family":"Phrommintikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,16]]},"reference":[{"issue":"23","key":"52_CR1","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"CW Hamm","year":"2011","unstructured":"Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(23):2999\u20133054.","journal-title":"Eur Heart J"},{"issue":"19","key":"52_CR2","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","volume":"163","author":"CB Granger","year":"2003","unstructured":"Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345\u201353.","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"52_CR3","first-page":"1","volume":"90","author":"S Srimahachota","year":"2007","unstructured":"Srimahachota S, Kanjanavanit R, Boonyaratavej S, Boonsom W, Veerakul G, Tresukosol D. Demographic, management practices and in-hospital outcomes of Thai Acute Coronary Syndrome Registry (TACSR): the difference from the Western world. J Med Assoc Thai. 2007;90 Suppl 1:1\u201311.","journal-title":"J Med Assoc Thai"},{"issue":"4","key":"52_CR4","first-page":"508","volume":"95","author":"S Srimahachota","year":"2012","unstructured":"Srimahachota S, Boonyaratavej S, Kanjanavanit R, Sritara P, Krittayaphong R, Kunjara-Na-ayudhya R, et al. Thai Registry in Acute Coronary Syndrome (TRACS)\u2013an extension of Thai Acute Coronary Syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year. J Med Assoc Thai. 2012;95(4):508\u201318.","journal-title":"J Med Assoc Thai"},{"key":"52_CR5","doi-asserted-by":"crossref","unstructured":"Pocock S, Bueno H, Licour M, Medina J, Zhang L, Annemans L, Danchin N, Huo Y, Van de Werf F. Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study. Eur Heart J Acute Cardiovasc Care. 2014.Epub ahead of print.","DOI":"10.1177\/2048872614554198"},{"issue":"20","key":"52_CR6","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1093\/eurheartj\/ehn362","volume":"29","author":"SA Murphy","year":"2008","unstructured":"Murphy SA, Antman EM, Wiviott SD, Weerakkody G, Morocutti G, Huber K, et al. Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial. Eur Heart J. 2008;29(20):2473\u20139.","journal-title":"Eur Heart J"},{"issue":"25","key":"52_CR7","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.jacc.2009.10.005","volume":"54","author":"SA Murphy","year":"2009","unstructured":"Murphy SA, Cannon CP, Wiviott SD, McCabe CH, Braunwald E. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial. J Am Coll Cardiol. 2009;54(25):2358\u201362.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"52_CR8","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMoa040583","volume":"350","author":"CP Cannon","year":"2004","unstructured":"Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350(15):1495\u2013504.","journal-title":"N Engl J Med"},{"issue":"11","key":"52_CR9","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","volume":"292","author":"JA de Lemos","year":"2004","unstructured":"de Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KA, White HD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA. 2004;292(11):1307\u201316.","journal-title":"JAMA"},{"issue":"7","key":"52_CR10","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S0895-4356(02)00405-5","volume":"55","author":"RC Kaplan","year":"2002","unstructured":"Kaplan RC, Heckbert SR, Furberg CD, Psaty BM. Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction. J Clin Epidemiol. 2002;55(7):654\u201364.","journal-title":"J Clin Epidemiol"},{"key":"52_CR11","unstructured":"Maharaj Nakorn Chiang Mai Hospital [http:\/\/www.med.cmu.ac.th\/2013\/academic-departments-2\/maharaj-nakorn-chiang-mai-hospital.html] Accessed 10 Feb 2015."},{"issue":"9","key":"52_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"14","key":"52_CR13","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","volume":"32","author":"Z Reiner","year":"2011","unstructured":"Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32(14):1769\u2013818.","journal-title":"Eur Heart J"},{"issue":"1","key":"52_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/oxfordjournals.aje.a115109","volume":"129","author":"BG Armstrong","year":"1989","unstructured":"Armstrong BG, Sloan M. Ordinal regression models for epidemiologic data. Am J Epidemiol. 1989;129(1):191\u2013204.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"52_CR15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/ije\/26.6.1323","volume":"26","author":"CV Ananth","year":"1997","unstructured":"Ananth CV, Kleinbaum DG. Regression models for ordinal responses: a review of methods and applications. Int J Epidemiol. 1997;26(6):1323\u201333.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"52_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.amjcard.2007.03.102","volume":"100","author":"JC LaRosa","year":"2007","unstructured":"LaRosa JC, Grundy SM, Kastelein JJ, Kostis JB, Greten H. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study). Am J Cardiol. 2007;100(5):747\u201352.","journal-title":"Am J Cardiol"},{"issue":"8","key":"52_CR17","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jacc.2005.04.064","volume":"46","author":"SD Wiviott","year":"2005","unstructured":"Wiviott SD, Cannon CP, Morrow DA, Ray KK, Pfeffer MA, Braunwald E. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: A PROVE IT-TIMI 22 Substudy. J Am Coll Cardiol. 2005;46(8):1411\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"52_CR18","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1093\/eurheartj\/ehl180","volume":"27","author":"KK Ray","year":"2006","unstructured":"Ray KK, Bach RG, Cannon CP, Cairns R, Kirtane AJ, Wiviott SD, et al. Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS. Eur Heart J. 2006;27(19):2310\u20136.","journal-title":"Eur Heart J"},{"key":"52_CR19","doi-asserted-by":"crossref","unstructured":"Chinwong D, Patumanond J, Chinwong S, Siriwattana K, Gunaparn S, Hall JJ, Phrommintikul A. Low-density lipoprotein cholesterol of less than 70\u00a0mg\/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real life cohort in Thailand. Ther Clin Risk Manag. Ther Clin Risk Manag. 2015; 11:659-67.","DOI":"10.2147\/TCRM.S78745"},{"issue":"5","key":"52_CR20","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ahj.2008.07.023","volume":"156","author":"CP Cannon","year":"2008","unstructured":"Cannon CP, Giugliano RP, Blazing MA, Harrington RA, Peterson JL, Sisk CM, et al. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe\/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J. 2008;156(5):826\u201332.","journal-title":"Am Heart J"},{"issue":"2","key":"52_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ahj.2014.05.004","volume":"168","author":"MA Blazing","year":"2014","unstructured":"Blazing MA, Giugliano RP, Cannon CP, Musliner TA, Tershakovec AM, White JA, et al. Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population. Am Heart J. 2014;168(2):205\u201312. e201.","journal-title":"Am Heart J"},{"key":"52_CR22","unstructured":"O\u2019Riordan, M. IMPROVE-IT: \u2018Modest\u2019 Benefit When Adding Ezetimibe to Statins in Post-ACS Patients [Available from: http:\/\/www.medscape.com\/viewarticle\/835030] Accessed 19 Nov 2014"},{"issue":"5","key":"52_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","volume":"8","author":"TA Jacobson","year":"2014","unstructured":"Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 - executive summary. J Clin Lipidol. 2014;8(5):473\u201388.","journal-title":"J Clin Lipidol"},{"issue":"25 Pt B","key":"52_CR24","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889\u2013934.","journal-title":"J Am Coll Cardiol"},{"key":"52_CR25","volume-title":"Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease","author":"National Institute for Health and Care Excellence","year":"2014","unstructured":"National Institute for Health and Care Excellence. Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease. London: National Clinical Guideline Centre; 2014."},{"issue":"3","key":"52_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/eurheartj\/ehl471","volume":"28","author":"C Held","year":"2007","unstructured":"Held C, Tornvall P, Stenestrand U. Effects of revascularization within 14\u00a0days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery. Eur Heart J. 2007;28(3):316\u201325.","journal-title":"Eur Heart J"},{"issue":"7","key":"52_CR27","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.amjcard.2005.05.046","volume":"96","author":"AT Yan","year":"2005","unstructured":"Yan AT, Yan RT, Tan M, Eagle KA, Granger CB, Dabbous OH, et al. In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score. Am J Cardiol. 2005;96(7):913\u20136.","journal-title":"Am J Cardiol"},{"issue":"25","key":"52_CR28","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","volume":"344","author":"CP Cannon","year":"2001","unstructured":"Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban. N Engl J Med. 2001;344(25):1879\u201387.","journal-title":"N Engl J Med"},{"key":"52_CR29","doi-asserted-by":"crossref","unstructured":"Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999, 354(9180):708\u2013715.","DOI":"10.1016\/S0140-6736(99)07349-3"},{"issue":"9335","key":"52_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(02)09894-X","volume":"360","author":"KA Fox","year":"2002","unstructured":"Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet. 2002;360(9335):743\u201351.","journal-title":"Lancet"},{"key":"52_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2261-6-21","volume":"6","author":"A Vanasse","year":"2006","unstructured":"Vanasse A, Courteau J, Niyonsenga T. Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients\u2019 survival when delivered as usual care. BMC Cardiovasc Disord. 2006;6:21.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"52_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2261-15-1","volume":"15","author":"R Bandara","year":"2015","unstructured":"Bandara R, Medagama A, Munasinghe R, Dinamithra N, Subasinghe A, Herath J, et al. Management and outcomes of acute ST-segment-elevation myocardial infarction at a tertiary-care hospital in Sri Lanka: an observational study. BMC Cardiovasc Disord. 2015;15(1):1.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"52_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.amjcard.2010.10.038","volume":"107","author":"F D\u2019Ascenzo","year":"2011","unstructured":"D\u2019Ascenzo F, Gonella A, Quadri G, Longo G, Biondi-Zoccai G, Moretti C, et al. Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction. Am J Cardiol. 2011;107(5):651\u20134.","journal-title":"Am J Cardiol"},{"issue":"7","key":"52_CR34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.amjmed.2012.01.014","volume":"125","author":"PW Wilson","year":"2012","unstructured":"Wilson PW, D\u2019Agostino Sr R, Bhatt DL, Eagle K, Pencina MJ, Smith SC, et al. An international model to predict recurrent cardiovascular disease. Am J Med. 2012;125(7):695\u2013703. e691.","journal-title":"Am J Med"},{"issue":"2","key":"52_CR35","first-page":"58","volume":"22","author":"MR Movahed","year":"2010","unstructured":"Movahed MR, Hashemzadeh M, Jamal MM, Ramaraj R. Decreasing in-hospital mortality of patients undergoing percutaneous coronary intervention with persistent higher mortality rates in women and minorities in the United States. J Invasive Cardiol. 2010;22(2):58\u201360.","journal-title":"J Invasive Cardiol"},{"issue":"24","key":"52_CR36","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/j.jacc.2008.01.066","volume":"51","author":"M Singh","year":"2008","unstructured":"Singh M, Rihal CS, Gersh BJ, Roger VL, Bell MR, Lennon RJ, et al. Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol. 2008;51(24):2313\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"52_CR37","first-page":"65","volume":"90","author":"B Srichaiveth","year":"2007","unstructured":"Srichaiveth B, Ruengsakulrach P, Visudharom K, Sanguanwong S, Tangsubutr W, Insamian P. Impact of gender on treatment and clinical outcomes in acute ST elevation myocardial infarction patients in Thailand. J Med Assoc Thai. 2007;90 Suppl 1:65\u201373.","journal-title":"J Med Assoc Thai"},{"issue":"6","key":"52_CR38","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1067\/mhj.2002.125504","volume":"144","author":"CR Walsh","year":"2002","unstructured":"Walsh CR, O\u2019Donnell CJ, Camargo Jr CA, Giugliano RP, Lloyd-Jones DM. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J. 2002;144(6):1003\u201311.","journal-title":"Am Heart J"},{"issue":"3","key":"52_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1157\/13086077","volume":"59","author":"L Facila","year":"2006","unstructured":"Facila L, Nunez J, Bodi V, Sanchis J, Bertomeu-Gonzalez V, Consuegra L, et al. Prognostic value of serum creatinine in non-ST-elevation acute coronary syndrome. Rev Esp Cardiol. 2006;59(3):209\u201316.","journal-title":"Rev Esp Cardiol"},{"issue":"10","key":"52_CR40","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1681\/ASN.2006010063","volume":"17","author":"P Jose","year":"2006","unstructured":"Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006;17(10):2886\u201391.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"52_CR41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0735-1097(01)01395-X","volume":"38","author":"HM Krumholz","year":"2001","unstructured":"Krumholz HM, Chen J, Chen YT, Wang Y, Radford MJ. Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol. 2001;38(2):453\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"52_CR42","first-page":"32","volume":"90","author":"K Sooklim","year":"2007","unstructured":"Sooklim K, Srimahachota S, Boonyaratavej S, Kanjanavanit R, Siriviwattanakul N, Piamsomboon C, et al. Renal dysfunction as an independent predictor of total mortality after acute coronary syndrome: the Thai ACS Registry. J Med Assoc Thai. 2007;90 Suppl 1:32\u201340.","journal-title":"J Med Assoc Thai"},{"issue":"4","key":"52_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3349\/ymj.2009.50.4.537","volume":"50","author":"YU Kang","year":"2009","unstructured":"Kang YU, Jeong MH, Kim SW. Impact of renal dysfunction on clinical outcomes of acute coronary syndrome. Yonsei Med J. 2009;50(4):537\u201345.","journal-title":"Yonsei Med J"},{"issue":"4","key":"52_CR44","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ahj.2007.11.031","volume":"155","author":"LM Mielniczuk","year":"2008","unstructured":"Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Shui A, et al. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J. 2008;155(4):725\u201331.","journal-title":"Am Heart J"},{"issue":"13","key":"52_CR45","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa041365","volume":"351","author":"NS Anavekar","year":"2004","unstructured":"Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285\u201395.","journal-title":"N Engl J Med"},{"issue":"8","key":"52_CR46","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1161\/01.CIR.0000027560.41358.B3","volume":"106","author":"J Al Suwaidi","year":"2002","unstructured":"Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106(8):974\u201380.","journal-title":"Circulation"},{"issue":"4","key":"52_CR47","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ahj.2004.07.019","volume":"149","author":"K Wattanakit","year":"2005","unstructured":"Wattanakit K, Folsom AR, Chambless LE, Nieto FJ. Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2005;149(4):606\u201312.","journal-title":"Am Heart J"},{"key":"52_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2261-8-34","volume":"8","author":"T Brugger-Andersen","year":"2008","unstructured":"Brugger-Andersen T, Ponitz V, Staines H, Pritchard D, Grundt H, Nilsen DW. B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study. BMC Cardiovasc Disord. 2008;8:34.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"52_CR49","doi-asserted-by":"publisher","first-page":"e003103","DOI":"10.1161\/JAHA.112.003103","volume":"2","author":"P Zamani","year":"2013","unstructured":"Zamani P, Schwartz GG, Olsson AG, Rifai N, Bao W, Libby P, et al. Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc. 2013;2(1):e003103.","journal-title":"J Am Heart Assoc"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-015-0052-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-015-0052-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-015-0052-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-015-0052-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T15:52:38Z","timestamp":1630597958000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-015-0052-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,16]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1186\/s12872-015-0052-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,16]]},"assertion":[{"value":"20 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"55"}}